Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Boehringer Ingelheim to initiate Phase III study in leukemia with its compound volasertib* based on positive Phase II results
Boehringer Ingelheim to initiate Phase III study in leukemia with its compound volasertib* based on positive Phase II results
Boehringer Ingelheim to initiate Phase III study in leukemia with its compound volasertib* based on positive Phase II results
Submitted by
admin
on December 11, 2012 - 11:31am
Source:
Pipeline Review
News Tags:
Boehringer Ingelheim
leukemia
volasertib
AML
acute myeloid leukemia
Headline:
Boehringer Ingelheim to initiate Phase III study in leukemia with its compound volasertib* based on positive Phase II results
Do Not Allow Advertisers to Use My Personal information
